- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
From InvestorPlace
From Benzinga
From InvestorPlace
From Benzinga
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
May 16, 2023
From Benzinga
From MarketWatch
From InvestorPlace
The 3 Best MedTech Stocks to Watch in May 2023
May 11, 2023
From InvestorPlace
From Benzinga
From Motley Fool
How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports
May 09, 2023
From Benzinga
2 Top Healthcare Stocks Defying the Bear Market
May 07, 2023
From Motley Fool
7 Hot Growth Stocks Poised to Triple in 2023
May 05, 2023
From InvestorPlace
What's Going On With Immix Biopharma Stock Today
May 03, 2023
From Benzinga
Insurers Can't Use War Argument: Court Rules in Favor of Merck in $1.4 Billion Cyberattack Coverage Case
May 03, 2023
Tickers
MRK
From Benzinga
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
May 01, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 28, 2023
From Benzinga
Germany's Possible Export Ban On Semiconductor Chemicals To China: What It Means For The U.S
April 27, 2023
From Benzinga
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
April 27, 2023
From Benzinga
Merck’s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet
April 27, 2023
From MarketWatch
Why Merck Stock Is Trading Higher Today
April 27, 2023
From Benzinga
From Motley Fool
Merck Makes a Bold Move That Could Transform Its Business
April 27, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.